Reduced sB7-H3 Expression in the Peripheral Blood of Systemic Lupus Erythematosus Patients

Table 2

Correlation between sB7-H3 and clinical features.

Clinical features		Case	sB7-H3 (pg/ml)
			Mean ± SD
Renal involvement	Yes	31	19,310 ± 858.1	0.8114
	No	47	18,900 ± 1236
Arthralgia	Yes	36	19,550 ± 1395	0.5671
	No	42	18,610 ± 939.6
Cutaneous manifestations	Yes	30	20,970 ± 1259	0.0158
	No	48	17,930 ± 1053
Photosensitivity	Yes	12	19,110 ± 921	0.7383
	No	66	18,140 ± 994.1
Alopecia	Yes	17	22,910 ± 733	0.1017
	No	61	18,290 ± 1165
Oral ulcers	Yes	18	21,340 ± 2800	0.2391
	No	60	18,640 ± 855.4
Fever	Yes	23	21,340 ± 2618	0.0968
	No	55	16,450 ± 1112
Raynaud’s phenomenon	Yes	16	24,110 ± 782	0.0347
	No	62	17,852 ± 1185
Proteinuria	Yes	43	18,830 ± 1022	0.5552
	No	35	19,750 ± 1141
Hypocomplementemia	Yes	54	19,350 ± 836.5	0.5178
	No	24	17,820 ± 1694
Hyperimmunoglobulinemia	Yes	25	19,450 ± 1647	0.8827
	No	53	19,190 ± 927.2
Erythrocytopenia	Yes	18	22,630 ± 2303	0.0166
	No	60	18,090 ± 719.8
Leukopenia	Yes	26	20,820 ± 1860	0.1546
	No	52	18,360 ± 778.3
Thrombocytopenia	Yes	11	23,450 ± 2740	0.0217
	No	67	18,060 ± 786.9
Anemia	Yes	23	22,110 ± 1669	0.0120
	No	55	17,830 ± 797.2

The t-test was used when the data distribution was confirmed as normal; otherwise, the nonparametric Mann–Whitney U test was used to analyze the data. was considered as statistically significant. The numbers of SLE patients are 78.